Market closed
GlaxoSmithKline/GSK
07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1Y5YMAX
About GlaxoSmithKline
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Ticker
GSK
Sector
Trading on
LSE
Industry
Pharmaceuticals
Headquarters
Employees
70,212
Website
GlaxoSmithKline Metrics
BasicAdvanced
£60B
Market cap
14.94
P/E ratio
£0.98
EPS
0.31
Beta
£0.59
Dividend rate
4.04%
Dividend yield
Price and volume
Market cap
£60B
Beta
0.31
52-week high
£18.24
52-week low
£13.71
Average daily volume
7.4M
Dividend rate
£0.59
Financial strength
Current ratio
0.824
Quick ratio
0.529
Long term debt to equity
98.598
Total debt to equity
123.043
Dividend payout ratio (TTM)
58.39%
Interest coverage (TTM)
13.55%
Management effectiveness
Return on assets (TTM)
9.56%
Return on equity (TTM)
33.30%
Valuation
Price to earnings (TTM)
14.936
Price to revenue (TTM)
1.887
Price to book
4.14
Price to tangible book (TTM)
-7.39
Price to free cash flow (TTM)
11.365
Dividend yield (TTM)
4.04%
Growth
Revenue change (TTM)
7.20%
Earnings per share change (TTM)
-74.03%
3-year revenue growth (CAGR)
3.48%
3-year earnings per share growth (CAGR)
-3.45%
3-year dividend per share growth (CAGR)
-15.66%
What the Analysts think about GlaxoSmithKline
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for GlaxoSmithKline stock.
GlaxoSmithKline Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
GlaxoSmithKline Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
GlaxoSmithKline News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe
Market closed
Upcoming events
Oct
10
GlaxoSmithKline
Dividend·Payment
£0.15
Per share
FAQs
What’s the current market cap for GlaxoSmithKline stock?
GlaxoSmithKline (GSK) has a market cap of £60B as of October 08, 2024.
What is the P/E ratio for GlaxoSmithKline stock?
The price to earnings (P/E) ratio for GlaxoSmithKline (GSK) stock is 14.94 as of October 08, 2024.
Does GlaxoSmithKline stock pay dividends?
Yes, the GlaxoSmithKline (GSK) stock pays dividends to shareholders. As of October 08, 2024, the dividend rate is £0.59 and the yield is 4.04%. GlaxoSmithKline has a payout ratio of 58.39% on a trailing twelve-month basis.
When is the next GlaxoSmithKline dividend payment date?
The next GlaxoSmithKline (GSK) dividend payment is scheduled for October 10, 2024.
What is the beta indicator for GlaxoSmithKline?
GlaxoSmithKline (GSK) has a beta rating of 0.31. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.